The presence of α-SMA(+) CAFs correlates with poor prognosis of HCC
CAFs regulate liver T-ICs through paracrine secretion of HGF
FRA1 is required for HGF/c-Met-mediated T-IC phenotypes
The HGF-mediated c-Met/FRA1/HEY1 cascade represents a therapeutic target for HCC